Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.41
-16.1%
$0.55
$0.39
▼
$1.96
$9.12M-2.6159,965 shs326,389 shs
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
$4.30
+1.4%
$4.52
$2.58
▼
$44.40
$20.20M-0.0429,344 shs63,269 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-9.92%-11.50%-4.88%-8.31%-51.21%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-6.40%-18.30%-16.54%+8.16%-81.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.41
-16.1%
$0.55
$0.39
▼
$1.96
$9.12M-2.6159,965 shs326,389 shs
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
$4.30
+1.4%
$4.52
$2.58
▼
$44.40
$20.20M-0.0429,344 shs63,269 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-9.92%-11.50%-4.88%-8.31%-51.21%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-6.40%-18.30%-16.54%+8.16%-81.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
1.50
ReduceN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BFRG and SHPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/10/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
DowngradeSell (E+) ➝ Sell (E)
10/14/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
UpgradeSell (E) ➝ Sell (E+)
10/2/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
UpgradeSell (E+) ➝ Sell (D-)
9/28/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
DowngradeSell (E+) ➝ Sell (E)
9/16/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
DowngradeSell (D-) ➝ Sell (E+)
9/9/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
UpgradeSell (E) ➝ Sell (E+)
8/21/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
DowngradeSell (E+) ➝ Sell (E)
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$120K63.78N/AN/A$0.27 per share1.52
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/A$11.14 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$6.50M-$0.42N/AN/AN/AN/A-135.33%-118.28%N/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-$11.72M-$18.64N/AN/AN/AN/A-168.34%-90.59%N/A

Latest BFRG and SHPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/13/2026Q3 2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$0.09-$0.11-$0.02-$0.11$0.22 million$0.06 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/AN/AN/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A
7.75
10.57
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/A
0.11
0.11

Institutional Ownership

CompanyInstitutional Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.96%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
4.58%

Insider Ownership

CompanyInsider Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
14.70%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
0.36%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
1718.69 million15.82 millionNot Optionable
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
24.76 million4.75 millionNot Optionable

Recent News About These Companies

Shuttle Pharmaceuticals Reports Delay in Quarterly Filing
SHPH Share News Today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bullfrog AI stock logo

Bullfrog AI NASDAQ:BFRG

$0.41 -0.08 (-16.05%)
Closing price 03:59 PM Eastern
Extended Trading
$0.41 0.00 (-0.12%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Shuttle Pharmaceuticals stock logo

Shuttle Pharmaceuticals NASDAQ:SHPH

$4.30 +0.06 (+1.42%)
Closing price 03:59 PM Eastern
Extended Trading
$4.18 -0.12 (-2.88%)
As of 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.